HBM Holdings Limited 6XY.F Stock
HBM Holdings Limited Price Chart
HBM Holdings Limited 6XY.F Financial and Trading Overview
| HBM Holdings Limited stock price | 0.14 EUR |
| Previous Close | 0.16 EUR |
| Open | 0.16 EUR |
| Bid | 0.19 EUR x N/A |
| Ask | 0.25 EUR x N/A |
| Day's Range | 0.16 - 0.16 EUR |
| 52 Week Range | 0.15 - 0.5 EUR |
| Volume | 1.61K EUR |
| Avg. Volume | 28 EUR |
| Market Cap | 144.44M EUR |
| Beta (5Y Monthly) | 1.336594 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0.03 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
6XY.F Valuation Measures
| Enterprise Value | 37.16M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.5523655 |
| Price/Book (mrq) | 1.28125 |
| Enterprise Value/Revenue | 0.914 |
| Enterprise Value/EBITDA | -0.317 |
Trading Information
HBM Holdings Limited Stock Price History
| Beta (5Y Monthly) | 1.336594 |
| 52-Week Change | -60.00000000000000000000000000000000% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.5 EUR |
| 52 Week Low | 0.15 EUR |
| 50-Day Moving Average | 0.21 EUR |
| 200-Day Moving Average | 0.25 EUR |
6XY.F Share Statistics
| Avg. Volume (3 month) | 28 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 744.32M |
| Float | 467.9M |
| Short Ratio | N/A |
| % Held by Insiders | 25.51% |
| % Held by Institutions | 20.89% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -299.78% |
| Gross Margin | 99.68% |
| EBITDA Margin | -288.39% |
Management Effectiveness
| Return on Assets (ttm) | -29.61% |
| Return on Equity (ttm) | -87.039% |
Income Statement
| Revenue (ttm) | 40.66M EUR |
| Revenue Per Share (ttm) | 0.06 EUR |
| Quarterly Revenue Growth (yoy) | 521.60% |
| Gross Profit (ttm) | N/A |
| EBITDA | -117260000 EUR |
| Net Income Avi to Common (ttm) | -137222000 EUR |
| Diluted EPS (ttm) | -0.17 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 172.5M EUR |
| Total Cash Per Share (mrq) | 0.24 EUR |
| Total Debt (mrq) | 90.93M EUR |
| Total Debt/Equity (mrq) | 98.3 EUR |
| Current Ratio (mrq) | 2.785 |
| Book Value Per Share (mrq) | 0.128 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of HBM Holdings Limited
| Country | Germany |
| State | N/A |
| City | Shanghai |
| Address | Tower A, 12th Floor |
| ZIP | 200032 |
| Phone | 86 21 5339 9123 |
| Website | https://www.harbourbiomed.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
HBM Holdings Limited, a clinical-stage biopharmaceutical company, engages in the discovery and development of differentiated antibody therapeutics in immunology and oncology disease areas. It is developing Batoclimab (HBM9161), a human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor; Tanfanercept (HBM9036) to treat moderate to-severe dry eye disease; HBM7008, a bispecific antibody targeting tumor Associated antigen; and HBM4003, a human anti-CTLA-4 antibody against cytotoxic T-lymphocyte-associated antigen-4. The company is also developing HBM9022 for the treatment of SARS-COV-2; HBM9302 for the treatment of breast and gastric cancers; HBM7020 for the treatment of multiple myeloma; and HBM1007, HBM1029, HBM7015, HBM7008, and HBM1022 for the treatment of solid tumors. It operates in Mainland China, the United States, Europe, and internationally. The company has collaboration on antibody-drug conjugate projects with LegoChem Biosciences Inc. and Duality Biotherapeutics, Inc. HBM Holdings Limited was incorporated in 2016 and is based in Shanghai, the People's Republic of China.
Q&A For HBM Holdings Limited Stock
What is a current 6XY.F stock price?
HBM Holdings Limited 6XY.F stock price today per share is 0.14 EUR.
How to purchase HBM Holdings Limited stock?
You can buy 6XY.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for HBM Holdings Limited?
The stock symbol or ticker of HBM Holdings Limited is 6XY.F.
Which industry does the HBM Holdings Limited company belong to?
The HBM Holdings Limited industry is Biotechnology.
How many shares does HBM Holdings Limited have in circulation?
The max supply of HBM Holdings Limited shares is 896.17M.
What is HBM Holdings Limited Price to Earnings Ratio (PE Ratio)?
HBM Holdings Limited PE Ratio is 4.73333360 now.
What was HBM Holdings Limited earnings per share over the trailing 12 months (TTM)?
HBM Holdings Limited EPS is 0.03 EUR over the trailing 12 months.
Which sector does the HBM Holdings Limited company belong to?
The HBM Holdings Limited sector is Healthcare.